RN7SK pseudogene 62 (RN7SKP62)

RN7SK pseudogene 62 (RN7SKP62) is classified as a pseudogene related to the 7SK small nuclear RNA gene. Pseudogenes are non-functional genomic DNA sequences similar to known genes but generally lack the ability to encode functional products. RN7SKP62 itself does not produce the functional 7SK small nuclear RNA, which is an important non-coding RNA involved in regulating transcription elongation in metazoans through sequestration of the positive transcription elongation factor P-TEFb[1][2]. The canonical 7SK RNA, but not its pseudogenes, is part of a ribonucleoprotein complex controlling gene expression and is not considered a receptor, enzyme, or therapeutic target[1][2]. RN7SK pseudogenes have no established biological function, disease association, interacting drugs, or mechanism of therapeutic action. The 7SK RNA itself is a well-characterized non-coding RNA critical for regulating transcription, but RN7SKP62 is a pseudogene and does not encode a functional product[1][2]. There are no data supporting RN7SKP62 as a therapeutic target, biomarker, or druggable entity. The inclusion of a pseudogene in a drug discovery or target list is incorrect unless there is a specific function/gain-of-function attributed to it, which does not apply here. There are many 7SK pseudogenes in the human genome, but only the canonical 7SK RNA is functionally characterized[2]. The RN7SKP62 locus is not known to encode a functional RNA or protein. RN7SK pseudogene 62 is a non-functional pseudogene of the 7SK small nuclear RNA and is not a recognized molecular target or participant in therapeutic mechanisms[1][2].

Other names

RNA, 7SK small nuclear pseudogene 62RN7SKP62